Featured insights
Why We Invested in Nivaan
16/2/2026
Thank you! Your submission has been received!
Click here to download the PDFOops! Something went wrong while submitting the form.
Why We Invested in Nivaan
16/2/2026
At Sorin, we look to back companies solving large, structurally broken problems with a clear path to building category leadership. Chronic pain management in India is one such market - affecting nearly 1 in 5 adults, yet largely addressed through fragmented care, prolonged physiotherapy, or (in some cases) avoidable surgeries.
